Serum cathepsin K in osteoporosis diagnosis

Rong WANG,Anda SHEN,Fuying ZHU,Yingliang ZHOU,Xiaoqian MU,Guangjie CHEN

DOI: https://doi.org/10.3969/j.issn.1673-8640.2016.08.003

2016-01-01

Abstract:Objective To investigate the levels of serum cathepsin K(Cathe K) in osteoporosis diagnosis. Methods Bone mineral densities of lumbar spine and femoral neck were measured by dual energy X-ray. According to bone mineral densities,187 objects were classified into 63 cases of bone loss and 124 cases of osteoporosis. In osteoporosis group,32 cases' drug treatment efficacy was monitored. A total of 142 healthy subjects were enrolled as healthy control group. Enzyme-linked immunosorbent assay was used to determine serum Cathe K and tartrate-resistant acid phosphatase(TRAP)levels. The levels of osteocalcin(N-MID),beta-collagen degradation product(β-crosslaps) and type Ⅰ procollagen N-terminal propeptide(PⅠNP)were determined by electrochemiluminescence immunoassay. According to ages,objects were classified into 35-45,46-55,56-65, 66-70 and ≥71-year-old groups. Results For 35-45,46-55 and 56-65-year-old groups,the levels of serum Cathe K in osteoporosis group were higher than those in healthy control group(P<0.01),but there was no statistical significance for 66-70 and ≥71-year-old groups between osteoporosis and healthy control groups (P>0.05). For 35-45-year-old group,the level of serum Cathe K in bone loss group was higher than that in healthy control group(P<0.01),and there was no statistical significance for the other age groups(P>0.05). In the analysis of bone turnover markers for 45-65-year-old groups,the levels of serum Cathe K,PⅠNP,β-crosslaps,N-MID and TRAP in osteoporosis group were higher than those in bone loss and healthy control groups(P<0.05). There was no statistical significance between bone loss and healthy control groups(P>0.05). Serum β-crosslaps and Cathe K decreased in osteoporosis group after treatment for 3 months(P<0.05). Conclusions Serum Cathe K can be used in the diagnosis and treatment monitoring of osteoporosis.